Log in
NASDAQ:ANGO

AngioDynamics Competitors

$12.52
-0.07 (-0.56 %)
(As of 11/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$12.46
Now: $12.52
$12.78
50-Day Range
$10.34
MA: $11.49
$12.59
52-Week Range
$7.48
Now: $12.52
$17.24
Volume212,180 shs
Average Volume287,863 shs
Market Capitalization$475.17 million
P/E RatioN/A
Dividend YieldN/A
Beta0.6

Competitors

AngioDynamics (NASDAQ:ANGO) Vs. ABT, MDT, SYK, ISRG, BDX, and EW

Should you be buying ANGO stock or one of its competitors? Companies in the sub-industry of "health care equipment" are considered alternatives and competitors to AngioDynamics, including Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), and Edwards Lifesciences (EW).

Abbott Laboratories (NYSE:ABT) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations.

Insider & Institutional Ownership

63.9% of Abbott Laboratories shares are held by institutional investors. Comparatively, 92.4% of AngioDynamics shares are held by institutional investors. 1.7% of Abbott Laboratories shares are held by company insiders. Comparatively, 3.8% of AngioDynamics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Abbott Laboratories and AngioDynamics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abbott Laboratories10.50%18.19%8.29%
AngioDynamics-62.90%0.18%0.15%

Valuation and Earnings

This table compares Abbott Laboratories and AngioDynamics' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abbott Laboratories$31.90 billion6.07$3.69 billion$3.2433.73
AngioDynamics$264.16 million1.80$-166,790,000.00$0.09139.11

Abbott Laboratories has higher revenue and earnings than AngioDynamics. Abbott Laboratories is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Abbott Laboratories has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Abbott Laboratories and AngioDynamics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abbott Laboratories141302.67
AngioDynamics01002.00

Abbott Laboratories presently has a consensus target price of $115.3750, indicating a potential upside of 5.59%. AngioDynamics has a consensus target price of $14.00, indicating a potential upside of 11.82%. Given AngioDynamics' higher probable upside, analysts clearly believe AngioDynamics is more favorable than Abbott Laboratories.

Summary

Abbott Laboratories beats AngioDynamics on 11 of the 14 factors compared between the two stocks.

Medtronic (NYSE:MDT) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Medtronic and AngioDynamics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medtronic132012.84
AngioDynamics01002.00

Medtronic presently has a consensus price target of $118.1538, indicating a potential upside of 6.47%. AngioDynamics has a consensus price target of $14.00, indicating a potential upside of 11.82%. Given AngioDynamics' higher probable upside, analysts plainly believe AngioDynamics is more favorable than Medtronic.

Insider and Institutional Ownership

79.9% of Medtronic shares are held by institutional investors. Comparatively, 92.4% of AngioDynamics shares are held by institutional investors. 0.5% of Medtronic shares are held by company insiders. Comparatively, 3.8% of AngioDynamics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Medtronic and AngioDynamics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$28.91 billion5.16$4.79 billion$4.5924.18
AngioDynamics$264.16 million1.80$-166,790,000.00$0.09139.11

Medtronic has higher revenue and earnings than AngioDynamics. Medtronic is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Medtronic and AngioDynamics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medtronic15.80%10.47%5.80%
AngioDynamics-62.90%0.18%0.15%

Volatility & Risk

Medtronic has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

Summary

Medtronic beats AngioDynamics on 12 of the 15 factors compared between the two stocks.

AngioDynamics (NASDAQ:ANGO) and Stryker (NYSE:SYK) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, analyst recommendations, dividends and profitability.

Institutional and Insider Ownership

92.4% of AngioDynamics shares are held by institutional investors. Comparatively, 71.0% of Stryker shares are held by institutional investors. 3.8% of AngioDynamics shares are held by insiders. Comparatively, 6.8% of Stryker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk and Volatility

AngioDynamics has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for AngioDynamics and Stryker, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AngioDynamics01002.00
Stryker291512.56

AngioDynamics currently has a consensus target price of $14.00, indicating a potential upside of 11.82%. Stryker has a consensus target price of $221.44, indicating a potential downside of 4.97%. Given AngioDynamics' higher possible upside, equities analysts clearly believe AngioDynamics is more favorable than Stryker.

Earnings and Valuation

This table compares AngioDynamics and Stryker's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AngioDynamics$264.16 million1.80$-166,790,000.00$0.09139.11
Stryker$14.88 billion5.88$2.08 billion$8.2628.21

Stryker has higher revenue and earnings than AngioDynamics. Stryker is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AngioDynamics and Stryker's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AngioDynamics-62.90%0.18%0.15%
Stryker11.38%20.53%8.89%

Summary

Stryker beats AngioDynamics on 13 of the 15 factors compared between the two stocks.

AngioDynamics (NASDAQ:ANGO) and Intuitive Surgical (NASDAQ:ISRG) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, profitability and risk.

Risk and Volatility

AngioDynamics has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.

Valuation and Earnings

This table compares AngioDynamics and Intuitive Surgical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AngioDynamics$264.16 million1.80$-166,790,000.00$0.09139.11
Intuitive Surgical$4.48 billion18.87$1.38 billion$9.9572.27

Intuitive Surgical has higher revenue and earnings than AngioDynamics. Intuitive Surgical is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AngioDynamics and Intuitive Surgical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AngioDynamics-62.90%0.18%0.15%
Intuitive Surgical24.45%12.08%10.44%

Analyst Ratings

This is a summary of recent ratings and target prices for AngioDynamics and Intuitive Surgical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AngioDynamics01002.00
Intuitive Surgical371202.41

AngioDynamics currently has a consensus price target of $14.00, indicating a potential upside of 11.82%. Intuitive Surgical has a consensus price target of $718.2778, indicating a potential downside of 0.11%. Given AngioDynamics' higher possible upside, analysts clearly believe AngioDynamics is more favorable than Intuitive Surgical.

Insider & Institutional Ownership

92.4% of AngioDynamics shares are held by institutional investors. Comparatively, 86.9% of Intuitive Surgical shares are held by institutional investors. 3.8% of AngioDynamics shares are held by insiders. Comparatively, 1.6% of Intuitive Surgical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Intuitive Surgical beats AngioDynamics on 11 of the 14 factors compared between the two stocks.

AngioDynamics (NASDAQ:ANGO) and Becton, Dickinson and (NYSE:BDX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk.

Earnings & Valuation

This table compares AngioDynamics and Becton, Dickinson and's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AngioDynamics$264.16 million1.80$-166,790,000.00$0.09139.11
Becton, Dickinson and$17.12 billion3.87$874 million$10.2022.40

Becton, Dickinson and has higher revenue and earnings than AngioDynamics. Becton, Dickinson and is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AngioDynamics and Becton, Dickinson and's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AngioDynamics-62.90%0.18%0.15%
Becton, Dickinson and5.11%13.30%5.60%

Volatility and Risk

AngioDynamics has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Becton, Dickinson and has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500.

Institutional & Insider Ownership

92.4% of AngioDynamics shares are held by institutional investors. Comparatively, 74.4% of Becton, Dickinson and shares are held by institutional investors. 3.8% of AngioDynamics shares are held by insiders. Comparatively, 0.1% of Becton, Dickinson and shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings for AngioDynamics and Becton, Dickinson and, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AngioDynamics01002.00
Becton, Dickinson and07712.60

AngioDynamics currently has a consensus price target of $14.00, suggesting a potential upside of 11.82%. Becton, Dickinson and has a consensus price target of $280.2857, suggesting a potential upside of 22.67%. Given Becton, Dickinson and's stronger consensus rating and higher possible upside, analysts plainly believe Becton, Dickinson and is more favorable than AngioDynamics.

Summary

Becton, Dickinson and beats AngioDynamics on 13 of the 15 factors compared between the two stocks.

AngioDynamics (NASDAQ:ANGO) and Edwards Lifesciences (NYSE:EW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation.

Analyst Recommendations

This is a summary of recent ratings and price targets for AngioDynamics and Edwards Lifesciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AngioDynamics01002.00
Edwards Lifesciences251302.55

AngioDynamics currently has a consensus target price of $14.00, indicating a potential upside of 11.82%. Edwards Lifesciences has a consensus target price of $87.7222, indicating a potential upside of 3.57%. Given AngioDynamics' higher possible upside, equities analysts clearly believe AngioDynamics is more favorable than Edwards Lifesciences.

Institutional & Insider Ownership

92.4% of AngioDynamics shares are held by institutional investors. Comparatively, 79.7% of Edwards Lifesciences shares are held by institutional investors. 3.8% of AngioDynamics shares are held by company insiders. Comparatively, 1.5% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

AngioDynamics has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

Valuation & Earnings

This table compares AngioDynamics and Edwards Lifesciences' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AngioDynamics$264.16 million1.80$-166,790,000.00$0.09139.11
Edwards Lifesciences$4.35 billion12.14$1.05 billion$1.8645.54

Edwards Lifesciences has higher revenue and earnings than AngioDynamics. Edwards Lifesciences is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AngioDynamics and Edwards Lifesciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AngioDynamics-62.90%0.18%0.15%
Edwards Lifesciences18.18%29.00%18.10%

Summary

Edwards Lifesciences beats AngioDynamics on 11 of the 14 factors compared between the two stocks.


AngioDynamics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Abbott Laboratories logo
ABT
Abbott Laboratories
2.2$109.27-1.5%$193.67 billion$31.90 billion57.82
Medtronic logo
MDT
Medtronic
2.7$110.97-0.7%$149.17 billion$28.91 billion33.94
Stryker logo
SYK
Stryker
2.0$233.01-0.1%$87.56 billion$14.88 billion55.35
Intuitive Surgical logo
ISRG
Intuitive Surgical
1.7$719.05-1.6%$84.53 billion$4.48 billion81.90
Becton, Dickinson and logo
BDX
Becton, Dickinson and
2.0$228.48-1.5%$66.23 billion$17.12 billion83.69Increase in Short Interest
Edwards Lifesciences logo
EW
Edwards Lifesciences
1.8$84.70-0.2%$52.79 billion$4.35 billion67.76
Boston Scientific logo
BSX
Boston Scientific
2.4$33.33-1.1%$47.73 billion$10.74 billion12.77
IDEXX Laboratories logo
IDXX
IDEXX Laboratories
1.5$459.79-1.0%$39.22 billion$2.41 billion80.10
Baxter International logo
BAX
Baxter International
2.3$75.77-1.6%$38.70 billion$11.36 billion43.05Increase in Short Interest
DexCom logo
DXCM
DexCom
2.1$321.09-1.6%$30.83 billion$1.48 billion132.68
ResMed logo
RMD
ResMed
1.7$209.57-0.7%$30.37 billion$2.96 billion49.08
Insulet logo
PODD
Insulet
1.3$265.89-0.2%$17.53 billion$738.20 million949.64
Hologic logo
HOLX
Hologic
1.9$68.07-1.4%$17.49 billion$3.37 billion16.21Analyst Downgrade
Teleflex logo
TFX
Teleflex
1.8$373.14-0.7%$17.38 billion$2.60 billion36.73
STERIS logo
STE
STERIS
1.9$189.09-3.5%$16.13 billion$3.03 billion39.31
Varian Medical Systems logo
VAR
Varian Medical Systems
1.4$173.50-0.0%$15.78 billion$3.23 billion56.51
Masimo logo
MASI
Masimo
1.6$245.50-1.0%$13.52 billion$937.84 million63.77
Abiomed logo
ABMD
Abiomed
1.5$266.43-0.7%$12.04 billion$840.88 million58.56
Hill-Rom logo
HRC
Hill-Rom
1.9$97.55-0.1%$6.52 billion$2.91 billion31.47Unusual Options Activity
Globus Medical logo
GMED
Globus Medical
1.5$58.47-1.1%$5.77 billion$785.37 million63.55
Integra LifeSciences logo
IART
Integra LifeSciences
1.4$54.78-0.5%$4.62 billion$1.52 billion81.76
Wright Medical Group logo
WMGI
Wright Medical Group
1.1$29.98-0.0%$3.90 billion$920.90 million-28.28
CONMED logo
CNMD
CONMED
1.5$103.32-2.0%$2.96 billion$955.10 million108.76Dividend Announcement
Insider Selling
NuVasive logo
NUVA
NuVasive
1.8$47.18-2.3%$2.42 billion$1.17 billion-214.45
Integer logo
ITGR
Integer
2.2$71.37-2.1%$2.35 billion$1.26 billion32.44
AtriCure logo
ATRC
AtriCure
1.5$43.24-1.8%$1.95 billion$230.81 million-37.60
Cardiovascular Systems logo
CSII
Cardiovascular Systems
1.7$34.90-1.2%$1.40 billion$236.54 million-52.88Analyst Downgrade
Alphatec logo
ATEC
Alphatec
1.2$10.55-2.4%$827.38 million$113.43 million-9.59
CryoLife logo
CRY
CryoLife
2.1$20.87-4.0%$810.95 million$276.22 million-54.92
Orthofix Medical logo
OFIX
Orthofix Medical
1.4$37.14-2.7%$718.07 million$459.95 million30.95
Surmodics logo
SRDX
Surmodics
1.5$38.12-2.4%$518.66 million$100.08 million68.07
Accuray logo
ARAY
Accuray
2.0$4.40-11.1%$401.61 million$382.93 million31.43High Trading Volume
Unusual Options Activity
Invacare logo
IVC
Invacare
1.4$8.98-1.1%$309.07 million$927.96 million-7.30
Rockwell Medical logo
RMTI
Rockwell Medical
1.3$0.94-1.1%$88.32 million$61.30 million-2.10
This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.